Trial Profile
A phase I/II study of sirolimus (Rapamune TM) in combination with cyclophosphamide and dexamethasone in relapsed myeloma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Jul 2019
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Cyclophosphamide; Dexamethasone
- Indications Myeloma
- Focus Adverse reactions
- Acronyms SCD1 Trial
- 03 Jul 2019 Status changed from active, no longer recruiting to completed.
- 25 May 2006 New trial record.